SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SRGN ( Seragen, Inc.) -- Ignore unavailable to you. Want to Upgrade?


To: Appleby who wrote (18)10/30/1997 1:52:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 52
 
ed, How close to approval is the DAB fusion protein? It seems that SRGN has several partnerships, but no money. I was also struck by the similarities between SRGN indications and some of LGND's targets (as well as a shared partner, LLY).